sec filing
AB
NASDAQ · ABUS
Arbutus Biopharma Corporation
Healthcare · Biotechnology
$4.06
Up+$0.18 (+4.64%)
Updated Nov 5, 2026, 9:14 AM
SID Score
3.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 896.23M
- P/E ratio
- -21.14
- Dividend yield
- 0.00%
- 52-week range
- $3.87 – $5.45
- Volume
- 2.78M
- Avg. volume
- 1.58M
Price performance · ABUS
ABUS price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
ABUS closed at $4.06 after 21 trading sessions, down 5.36% for the selected period.
- Last close
- $4.06
- Period change
- -5.36%
- Period low
- $3.88
- Period high
- $4.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $3.98 | $4.075 | $3.87 | $4.06 | 2.78M |
| Nov 3, 2026 | $4.01 | $4.055 | $3.87 | $3.88 | 2.39M |
| Nov 2, 2026 | $4.22 | $4.29 | $3.99 | $4.00 | 2.65M |
| Oct 30, 2026 | $4.28 | $4.3045 | $4.1413 | $4.21 | 2.53M |
| Oct 29, 2026 | $4.34 | $4.38 | $4.23 | $4.28 | 1.21M |
| Oct 28, 2026 | $4.24 | $4.33 | $4.22 | $4.32 | 1.34M |
| Oct 27, 2026 | $4.20 | $4.295 | $4.18 | $4.29 | 1.62M |
| Oct 26, 2026 | $4.22 | $4.26 | $4.18 | $4.20 | 1.41M |
| Oct 23, 2026 | $4.17 | $4.22 | $4.1211 | $4.20 | 2.03M |
| Oct 22, 2026 | $4.22 | $4.37 | $4.175 | $4.21 | 2.46M |
| Oct 21, 2026 | $4.32 | $4.35 | $4.17 | $4.18 | 3.03M |
| Oct 20, 2026 | $4.24 | $4.365 | $4.22 | $4.33 | 2.11M |
| Oct 19, 2026 | $4.24 | $4.28 | $4.15 | $4.23 | 1.96M |
| Oct 16, 2026 | $4.29 | $4.29 | $4.18 | $4.22 | 4.54M |
| Oct 15, 2026 | $4.23 | $4.30 | $4.215 | $4.29 | 2.28M |
| Oct 14, 2026 | $4.07 | $4.25 | $4.05 | $4.19 | 2.43M |
| Oct 13, 2026 | $4.13 | $4.155 | $4.05 | $4.11 | 3.48M |
| Oct 12, 2026 | $4.20 | $4.23 | $4.12 | $4.15 | 2.34M |
| Oct 9, 2026 | $4.17 | $4.27 | $4.13 | $4.22 | 3.15M |
| Oct 8, 2026 | $4.22 | $4.30 | $4.05 | $4.18 | 4.85M |
| Oct 7, 2026 | $4.46 | $4.48 | $4.28 | $4.29 | 4.79M |
Latest ABUS news
The latest Smart Investors Daily articles mentioning ABUS.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…